The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

4726–4750 of 11819

  • SevereFDA (Drugs)·D-1637-2019·2019-08-14

    RXQ Compounding Recalls Avastin Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Avastin 25mg/mL syringes because the company cannot ensure the product is sterile. The recall covers all lots within their expiration dates.

    Product
    Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1675-2019·2019-08-14

    RXQ Compounding Recalls Magnesium Chloride Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Magnesium Chloride Hexahydrate 20% Injection Solution because the product lacks assurance of sterility.

    Product
    MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0951-50
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1710-2019·2019-08-14

    RXQ Compounding Recalls Thiamine HCL Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Thiamine HCL 100mg/mL Injection because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0950-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1638-2019·2019-08-14

    RXQ Compounding Recalls Buffered Lidocaine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Buffered Lidocaine 1%+Epi 1:100,000 Injection Solution because the product lacks assurance of sterility.

    Product
    BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0137-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1655-2019·2019-08-14

    RXQ Compounding Recalls Ephedrine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ephedrine 5mg/mL syringes nationwide because the product lacks assurance of sterility.

    Product
    EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0201-85
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1719-2019·2019-08-14

    RXQ Compounding Recalls Zinc Sulfate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Zinc Sulfate 1mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    ZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0152-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1716-2019·2019-08-14

    RXQ Compounding Recalls Vitamin B Complex 100 Due to Sterility Concerns

    RXQ Compounding LLC is recalling Vitamin B Complex 100 (MDV) vials because the product lacks assurance of sterility.

    Product
    VITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0976-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1703-2019·2019-08-14

    RXQ Compounding Recalls Phenylephrine and Lidocaine Ophthalmic Solution

    RXQ Compounding LLC is recalling ophthalmic solution vials due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1705-2019·2019-08-14

    RXQ Compounding Recalls Lidocaine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine 0.75%/Epinephrine 0.025% syringes because the FDA determined there is a lack of assurance of sterility.

    Product
    LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0919-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1689-2019·2019-08-14

    RXQ Compounding Recalls Niacinamide Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Niacinamide 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0938-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1665-2019·2019-08-14

    RXQ Compounding Recalls Hydromorphone Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling hydromorphone syringes because the company cannot ensure the product is sterile.

    Product
    HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1659-2019·2019-08-14

    RXQ Compounding Recalls Fentanyl and Bupivacaine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Fentanyl and Bupivacaine syringes nationwide due to a lack of assurance of sterility.

    Product
    FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1636-2019·2019-08-14

    RXQ Compounding Recalls Ascorbic Acid Injection Due to Crystallization

    RXQ Compounding LLC is voluntarily recalling Ascorbic Acid 500 MG/ML Injection due to crystallization. The recall covers all lots within expiry distributed nationwide.

    Product
    Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0975-50
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1609-2019·2019-08-14

    Herbal Doctor Remedies Recalls Lung Tonic EX Capsules for Manufacturing Deviations

    Herbal Doctor Remedies is recalling Lung Tonic EX Capsules because they were manufactured outside of required Good Manufacturing Practices controls.

    Product
    Lung Tonic EX Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1664-2019·2019-08-14

    RXQ Compounding Recalls Hydrogen Peroxide Injectable Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydrogen Peroxide 3% Injectable PFV because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0907-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1837-2019·2019-08-07

    Jubilant Cadista Recalls Drospirenone and Ethinyl Estradiol Tablets for Dissolution Failure

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Drospirenone and Ethinyl Estradiol Tablets because they failed dissolution specifications during stability testing.

    Product
    Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadis
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1567-2019·2019-08-07

    Wise Pharmacy Recalls Acetylcysteine Otic Drops Due to Processing Controls

    Wise Pharmacy is recalling Acetylcysteine 2% Otic Drops due to a lack of processing controls. The product was distributed in Colorado, Texas, and Wyoming.

    Product
    Acetylcysteine 2% Otic Drop, 15 mL bottle, Rx only, Refrigerate, Compounded by Wise Pharmacy, Littleton, CO 80123.
    Category
    Drug
    Distribution
    3 states
  • SevereFDA (Drugs)·D-1577-2019·2019-08-07

    Wise Pharmacy Recalls Compounded Papaverine Injectable Due to Processing Controls

    Wise Pharmacy is recalling 14 vials of compounded Papaverine/Phentolamine/Alprostadil/Atropine injectable due to a lack of processing controls.

    Product
    Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.
    Category
    Drug
    Distribution
    3 states
  • SevereFDA (Drugs)·D-1579-2019·2019-08-07

    ImprimisRx Recalls Subpotent Timolol-Dorzolamide-Latanoprost Ophthalmic Drops

    ImprimisRx NJ is recalling 246 bottles of Timolol-Dorzolamide-Latanoprost ophthalmic drops because the medication was found to be subpotent.

    Product
    Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1578-2019·2019-08-07

    ImprimisRx Recalls Subpotent Timolol-Latanoprost Ophthalmic Drops Nationwide

    ImprimisRx NJ is voluntarily recalling 405 bottles of Timolol-Latanoprost P-F ophthalmic drops because the medication was found to be subpotent.

    Product
    Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRX NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1522-2019·2019-07-31

    Geritrex Recalls Gericare Diocto Liquid Stool Softener Due to Microbial Contamination Risk

    Geritrex, LLC is recalling 6,165 bottles of Gericare Diocto Liquid Stool Softener due to cGMP deviations that may result in microbial contamination.

    Product
    Gericare Diocto Liquid Docusate Sodium Stool Softener, 50 mg/5mL, 16 FL OZ (473 ml), Dist. BY: Gericare Pharmaceuticals corp. 1650 63rd Street Brooklyn, NY 11204, NDC 57896-403-16
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1521-2019·2019-07-31

    Geritrex Recalls Ritussin DM Due to Potential Microbial Contamination

    Geritrex, LLC is recalling 5,107 bottles of Ritussin DM Children & Adults due to cGMP deviations that may result in microbial contamination.

    Product
    Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1525-2019·2019-07-31

    Geritrex Recalls Ritussin DM Due to Potential Microbial Contamination

    Geritrex, LLC is recalling Ritussin DM Double Strength cough syrup due to cGMP deviations that may result in microbial contamination.

    Product
    Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1528-2019·2019-07-31

    Gordon Laboratories Recalls MONSEL'S Solution Due to Microbial Contamination

    Gordon Laboratories is recalling 277 boxes of MONSEL'S (Ferric Subsulfate) Solution due to microbial contamination and high iron content.

    Product
    MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA 19082, NDC 10481-0112-8.
    Category
    Drug
    Distribution
    Distributed nationwide